Edition:
India

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

25.39CAD
15 Dec 2017
Change (% chg)

$0.28 (+1.12%)
Prev Close
$25.11
Open
$25.17
Day's High
$26.13
Day's Low
$24.58
Volume
5,137,969
Avg. Vol
1,798,295
52-wk High
$29.28
52-wk Low
$11.20

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

CANADA STOCKS-TSX advances, lifted by Valeant, financial services

TORONTO, Dec 12 Canada's main stock index rose on Tuesday, led by gains in drugmaker Valeant Pharmaceuticals and in the financial services sector.

12 Dec 2017

BRIEF-Valeant Announces Pricing Of Private Offering Of Senior Notes

Dec 4 Valeant Pharmaceuticals International Inc :

05 Dec 2017

BRIEF-Valeant, Unit Announce Upsize of Cash Tender Offers

Dec 4 Valeant Pharmaceuticals International Inc :

05 Dec 2017

BRIEF-Valeant Announces Launch Of Private Offering Of Senior Notes

Dec 4 Valeant Pharmaceuticals International Inc :

04 Dec 2017

BRIEF-Valeant announces closing of add-on secured notes and credit agreement amendment

* Valeant announces closing of add-on secured notes and credit agreement amendment Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-Valeant announces pricing of private offering of add-on secured notes

* Valeant announces pricing of private offering of add-on secured notes

15 Nov 2017

BRIEF-Valeant announces launch of private offering of add-on secured notes

* Valeant announces launch of private offering of add-on secured notes

13 Nov 2017

BRIEF-Valeant Pharmaceuticals amends existing credit agreement

Nov 9 Valeant Pharmaceuticals International Inc :

09 Nov 2017

Competitors

Earnings vs. Estimates